STOCK TITAN

Southern Cross II flags 12-month liquidation risk

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Southern Cross Acquisition II Corp. (SCAT) reported third-quarter net income of $59,422 and nine-month net income of $12,103, with no operating revenue. The quarterly result included $271,205 of trust investment income and a $95,146 gain from the change in over-allotment liability, offset by $122,607 of formation and operating costs and $184,322 of stock compensation expense. After its August 27, 2026 IPO of 7,652,630 units at $10 per unit, SCAT held $76,988,821 in its trust account and $549,479 in cash outside it as of September 30, 2026.

SCAT has not selected a business-combination target or begun substantive discussions with prospects. It must complete a business combination within 12 months after the IPO unless the period is extended; otherwise, it must cease operations, redeem public shares and liquidate. Management believes cash outside the trust account, together with Working Capital Loans if necessary, will meet working-capital needs for at least one year from issuance, but determined the mandatory liquidation provision raises substantial doubt about the company’s ability to continue as a going concern.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

How the balance works

Positive

  • None.

Negative

  • Major point12-month combination deadline raises substantial doubt about going concern.

Filing Explained

Public rights convert into one-quarter share each only when a combination closes, while warrants allow later one-share purchases for eleven dollars and fifty cents.

Form 10-Q is the unaudited quarterly report; this filing also records that the remaining IPO over-allotment option expired on October 11, 2026. On November 2, 2026, the sponsor forfeited 324,123 founder shares, changing the founder-share ownership structure. The filing reports 10,581,492 ordinary shares outstanding on November 13, 2026.

As of September 30, 2026, 7,652,630 public rights and 224,932 private rights were outstanding; each right delivers one-quarter of an ordinary share automatically, without additional payment, when a business combination is completed. On that date, 7,652,630 public warrants and 224,932 private warrants were outstanding; each whole warrant allows its holder to buy one ordinary share for $11.50, becoming exercisable on the later of 30 days after a business combination and one year from the IPO registration statement’s effective date. If rights convert or warrants are exercised, the resulting additional shares increase the share count and reduce existing holders’ percentage ownership, absent offsetting changes.

Third-quarter net income $59,422 Three months ended September 30, 2026.
Nine-month net income $12,103 Nine months ended September 30, 2026.
Trust account investments $76,988,821 Balance as of September 30, 2026.
Cash outside the trust account $549,479 Balance as of September 30, 2026.
Working capital $411,271 As of September 30, 2026.
Operating cash used $166,991 Nine months ended September 30, 2026.
Public shares subject to possible redemption 7,652,630 shares At a redemption value of $10.06 per share as of September 30, 2026.
IPO gross proceeds $76,526,300 IPO closed August 27, 2026.
Business Combination technical
"formed for the purpose of effecting a Business Combination"
A business combination happens when two or more companies join together to operate as one, like two friends merging their teams into a single group. This is important because it can change how companies grow, compete, and make money, often making them bigger and more powerful in the market.
Trust Account financial
"investments held in Trust Account"
A trust account is a special bank or brokerage account where assets are held and managed by a designated person or firm (the trustee) for the benefit of another person or group (the beneficiary). It matters to investors because it separates assets from personal or corporate funds, can protect assets, control how and when money is used, and may affect tax or legal rights—think of it as a locked drawer opened only under agreed rules.
Working Capital Loans financial
"may, but are not obligated to, loan the Company funds"
Working capital loans are short-term loans companies use to cover everyday operational expenses—such as payroll, inventory purchases, or utility bills—when incoming cash is delayed or uneven. Investors care because frequent or growing reliance on these loans can signal ongoing cash-flow stress and higher financial risk, while occasional use can simply smooth predictable ups and downs; like a household using a short-term loan to bridge paychecks, it affects a company’s short-term stability and flexibility.
temporary equity financial
"presented at redemption value as temporary equity"
Equity-like securities that accounting rules require to be reported separately from permanent shareholders’ equity because the holder can force or the issuer is obligated to settle them in cash or other assets (or they will be settled on a specified date). Examples include mandatorily redeemable shares and certain convertible instruments with required cash settlement; on the balance sheet they appear between liabilities and shareholders’ equity (often called mezzanine or temporary equity) rather than as part of common equity.
over-allotment liability financial
"change in fair value of the over-allotment liability"
cashless basis financial
"holders may exercise the warrants on a cashless basis"
An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What happens to SCAT public shares and rights if no business combination is completed?

If SCAT does not complete a business combination within 12 months after the IPO, unless the period is extended, public shares are to be redeemed for cash at a per-share amount based on trust-account funds, including interest, net of income taxes and up to $100,000 of interest for liquidation expenses. Rights expire worthless and receive no trust-account distribution.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒     QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

☐     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to __________

 

Commission File Number  001-43443

 

Southern Cross Acquisition II Corp.

(Exact name of registrant as specified in its charter)

 

Cayman Islands

 

N/A

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

 

1412 Broadway

21st Floor Suite 21V

New York, NY 10018

(Address of principal executive offices and zip code)

 

(646) 257-5537

(Registrant’s telephone number, including area code)

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol

 

Name of each exchange on which registered

Units, consisting of one ordinary share, $0.0001 par value, one redeemable Warrant to acquire one ordinary share, and one Right to acquire one-fourth of one ordinary share

 

SCATU

 

The Nasdaq Stock Market LLC

Ordinary shares, par value $0.0001 per share

 

SCAT

 

The Nasdaq Stock Market LLC

Redeemable Warrants, each whole warrant exercisable for one ordinary share at an exercise price of $11.50

 

SCATW

 

The Nasdaq Stock Market LLC

Rights, each whole right to acquire one-fourth of one ordinary share

 

SCATR

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒     No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes ☒     No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☒

 

 

Emerging growth company

☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒     No ☐

 

As of November 13, 2026, there were 10,581,492 of the registrant’s ordinary shares, par value $0.0001 per share, issued and outstanding.

 

 

 

 

Southern Cross Acquisition II Corp.

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION

 

3

 

Item 1. FINANCIAL STATEMENTS (UNAUDITED)

 

3

 

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

23

 

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

30

 

Item 4. CONTROLS AND PROCEDURES

 

30

 

PART II – OTHER INFORMATION

 

31

 

Item 1. LEGAL PROCEEDINGS

 

31

 

Item 1A. RISK FACTORS

 

31

 

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS FROM REGISTERED SECURITIES

 

31

 

Item 3. DEFAULTS UPON SENIOR SECURITIES

 

31

 

Item 4. MINE SAFETY DISCLOSURES

 

31

 

Item 5. OTHER INFORMATION

 

31

 

Item 6. EXHIBITS

 

32

 

SIGNATURES

 

33

 

 

 
2

Table of Contents

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

SOUTHERN CROSS ACQUISITION II CORP.

BALANCE SHEETS

(UNAUDITED)

 

 

 

September 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Asset

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

Cash

 

$549,479

 

 

$-

 

Prepaid expenses

 

 

80,489

 

 

 

-

 

Total Current Assets

 

 

629,968

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Non-current Asset

 

 

 

 

 

 

 

 

Investments held in Trust Account

 

 

76,988,821

 

 

 

-

 

Total Asset

 

$77,618,789

 

 

$-

 

 

 

 

 

 

 

 

 

 

Liabilities, Ordinary Shares Subject to Possible Redemptions and Shareholders' Equity (Deficit)

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Accrued expenses

 

$90,198

 

 

$6,774

 

Promissory note - related party

 

 

-

 

 

 

3,683

 

Over-allotment liability

 

 

128,499

 

 

 

-

 

Total Current Liabilities

 

 

218,697

 

 

 

10,457

 

Total Liabilities

 

 

218,697

 

 

 

10,457

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies (Note 6)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ordinary shares, $0.0001 par value, 490,000,000 shares authorized, 7,652,630 and 0 shares subject to possible redemption, at redemption value of $10.06 and $0 per share as of September 30, 2026 and December 31, 2025, respectively

 

 

76,988,821

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Shareholder's Equity (Deficit):

 

 

 

 

 

 

 

 

Preferred shares, $0.0001 par value, 10,000,000 shares authorized, none issued and outstanding

 

 

-

 

 

 

-

 

Ordinary shares, $0.0001 par value, 490,000,000 shares authorized, 3,252,985 and 2,875,000 shares issued and outstanding (1) (2) (excluding 7,652,630 and 0 shares subject to possible redemption) as of September 30, 2026 and December 31, 2025, respectively

 

 

325

 

 

 

288

 

Additional paid-in capital

 

 

409,300

 

 

 

24,712

 

Subscription receivable

 

 

-

 

 

 

(25,000)

Retained earnings (accumulated deficit)

 

 

1,646

 

 

 

(10,457)

Total Shareholder's Equity (Deficit)

 

 

411,271

 

 

 

(10,457)

Total Liabilities, Ordinary Shares Subject to Possible Redemptions and Shareholder’s Equity (Deficit)

 

$77,618,789

 

 

$-

 

 

(1)

This number includes an aggregate of up to 324,123 ordinary shares, which were forfeited on November 2, 2026, as the over-allotment option expired on October 11, 2026 (see Note 5).

 

 

(2)

On May 26, 2026, (i) the Sponsor acquired 2,875,000 founder shares for a purchase price of $25,000, and (ii) the Sponsor surrendered 1 ordinary share, all share amount have been retroactively restated to reflect this issuance, and surrender of shares (see Note 5).

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 
3

Table of Contents

 

SOUTHERN CROSS ACQUISITION II CORP.

STATEMENT OF OPERATIONS

(UNAUDITED)

 

 

 

For the Three

Months Ended

September 30, 2026

 

 

For the Nine

Months Ended

September 30, 2026

 

 

For the Period From

September 30, 2025

(Inception) Through

September 30, 2025

 

 

 

 

 

 

 

 

 

 

 

Formation and operating costs

 

$122,607

 

 

$169,926

 

 

$3,683

 

Stock compensation expense

 

 

184,322

 

 

 

184,322

 

 

 

-

 

Loss from operations

 

 

(306,929)

 

 

(354,248)

 

 

(3,683)

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of over-allotment liability

 

 

95,146

 

 

 

95,146

 

 

 

-

 

Interest and dividend income on investments held in Trust Account

 

 

271,205

 

 

 

271,205

 

 

 

-

 

Total other income

 

 

366,351

 

 

 

366,351

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$59,422

 

 

$12,103

 

 

$(3,683)

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted weighted average shares outstanding, ordinary shares subject to possible redemption

 

 

2,828,146

 

 

 

953,075

 

 

 

-

 

Basic and diluted income per share, ordinary shares subject to possible redemption

 

$0.01

 

 

$0.00

 

 

$-

 

Basic and diluted weighted average shares outstanding, non-redeemable ordinary shares (1) (2)

 

 

2,658,492

 

 

 

2,544,092

 

 

 

2,500,000

 

Basic and diluted net income (loss) per share, non-redeemable ordinary shares

 

$0.01

 

 

$0.00

 

 

$(0.00)

 

(1)

This number includes an aggregate of up to 324,123 ordinary shares, which were forfeited on November 2, 2026, as the over-allotment option expired on October 11, 2026 (see Note 5).

 

 

(2)

On May 26, 2026, (i) the Sponsor acquired 2,875,000 founder shares for a purchase price of $25,000, and (ii) the Sponsor surrendered 1 ordinary share, all share amount have been retroactively restated to reflect this issuance, and surrender of shares (see Note 5).

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 
4

Table of Contents

 

SOUTHERN CROSS ACQUISITION II CORP.

STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY (DEFICIT)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND FOR THE PERIOD FROM SEPTEMBER 30, 2025 (INCEPTION) THROUGH SEPTEMBER 30, 2025

(UNAUDITED)

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 Total

 

 

 

Preferred Shares

 

 

Ordinary Shares

 

 

Paid-in

 

 

Subscription

 

 

Retained

 

 

 Shareholders'

 

 

 

Shares

 

 

Amount

 

 

Shares(1) (2)

 

 

Amount

 

 

Capital

 

 

Receivable

 

 

 Earnings

 

 

 Equity

 

Balance as of December 31, 2025

 

 

-

 

 

$-

 

 

 

2,875,000

 

 

$288

 

 

$24,712

 

 

$(25,000)

 

$(10,457)

 

$(10,457)

Collection of subscription receivable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

25,000

 

 

 

-

 

 

 

25,000

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,055)

 

 

(1,055)

Balance as of March 31, 2026

 

 

-

 

 

 

-

 

 

 

2,875,000

 

 

 

288

 

 

 

24,712

 

 

 

-

 

 

 

(11,512)

 

 

13,488

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(46,264)

 

 

(46,264)

Balance as of June 30, 2026

 

 

-

 

 

 

-

 

 

 

2,875,000

 

 

 

288

 

 

 

24,712

 

 

 

-

 

 

 

(57,776)

 

 

(32,776)

Sale of private placement units, including over-allotment

 

 

-

 

 

 

-

 

 

 

224,932

 

 

 

22

 

 

 

2,249,298

 

 

 

-

 

 

 

-

 

 

 

2,249,320

 

Issuance of representative shares

 

 

-

 

 

 

-

 

 

 

153,053

 

 

 

15

 

 

 

515,774

 

 

 

-

 

 

 

-

 

 

 

515,789

 

Fair value of rights and warrants included in public units

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

9,308,924

 

 

 

-

 

 

 

-

 

 

 

9,308,924

 

Allocated value of transaction costs to rights and warrants included in public units

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(243,180)

 

 

-

 

 

 

-

 

 

 

(243,180)

Initial measurement of carrying value to redemption value

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(11,359,345)

 

 

-

 

 

 

-

 

 

 

(11,359,345)

Remeasurement of carrying value to redemption value

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(271,205)

 

 

-

 

 

 

-

 

 

 

(271,205)

Stock compensation expense

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

184,322

 

 

 

-

 

 

 

-

 

 

 

184,322

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

59,422

 

 

 

59,422

 

Balance as of September 30, 2026

 

 

-

 

 

$-

 

 

 

3,252,985

 

 

$325

 

 

$409,300

 

 

$-

 

 

$1,646

 

 

$411,271

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 Total

 

 

 

Preferred Shares

 

 

Ordinary Shares

 

 

Paid-in

 

 

Subscription

 

 

Accumulated

 

 

 Shareholder's

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Receivable

 

 

 Deficit

 

 

 Deficit

 

Balance as of September 30, 2025 (Inception)

 

 

-

 

 

$-

 

 

 

-

 

 

$-

 

 

$-

 

 

$-

 

 

$-

 

 

$-

 

Issuance of ordinary shares to Sponsor(1) (2)

 

 

-

 

 

 

-

 

 

 

2,875,000

 

 

 

 288

 

 

 

24,712

 

 

 

(25,000

) 

 

 

-

 

 

 

-

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3,683)

 

 

(3,683)

Balance as of September 30, 2025

 

 

-

 

 

$-

 

 

 

2,875,000

 

 

$288

 

 

$24,712

 

 

$(25,000

)

 

$(3,683)

 

$(3,683)

 

(1)

This number includes an aggregate of up to 324,123 ordinary shares, which were forfeited on November 2, 2026, as the over-allotment option expired on October 11, 2026 (see Note 5).

 

 

(2)

On May 26, 2026, (i) the Sponsor acquired 2,875,000 founder shares for a purchase price of $25,000, and (ii) the Sponsor surrendered 1 ordinary share, all share amount have been retroactively restated to reflect this issuance, and surrender of shares (see Note 5).

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 
5

Table of Contents

 

SOUTHERN CROSS ACQUISITION II CORP.

STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

 

 

For The Nine

Months Ended

September 30, 2026

 

 

For The Period From

September 30, 2025

 (Inception) Through

September 30, 2025

 

Cash Flows from Operating Activities:

 

 

 

 

 

 

Net income (loss)

 

$12,103

 

 

$(3,683)

Adjustments to reconcile net income (loss) to net cash used in operating activities

 

 

 

 

 

 

 

 

Formation and operating costs paid by Sponsor

 

 

-

 

 

 

3,683

 

Stock compensation expense

 

 

184,322

 

 

 

-

 

Change in fair value of over-allotment liability

 

 

(95,146)

 

 

-

 

Interest and dividend income on investments held in Trust Account

 

 

(271,205)

 

 

-

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Prepaid expenses

 

 

(80,489)

 

 

-

 

Accrued expenses

 

 

83,424

 

 

 

-

 

Net Cash Used in Operating Activities

 

 

(166,991)

 

 

-

 

 

 

 

 

 

 

 

 

 

Cash Flows from Investing Activity:

 

 

 

 

 

 

 

 

Purchase of investments held in trust account

 

 

(76,717,616)

 

 

 

 

Net Cash Used in investing Activity

 

 

(76,717,616)

 

 

-

 

 

 

 

 

 

 

 

 

 

Cash Flows from Financing Activities:

 

 

 

 

 

 

 

 

Proceeds from issuance of ordinary shares

 

 

25,000

 

 

 

-

 

Proceeds from public offering

 

 

76,526,300

 

 

 

-

 

Proceeds from private placement

 

 

2,058,000

 

 

 

-

 

Proceeds from promissory note - related party

 

 

375,000

 

 

 

-

 

Repayment of promissory note - related party

 

 

(328,000)

 

 

-

 

Repayment of due to related party

 

 

(50,683)

 

 

 

 

Payment of underwriter discount, net of private units subscription by underwriter

 

 

(723,680)

 

 

-

 

Payment of offering costs

 

 

(447,851)

 

 

-

 

Net Cash Provided by Financing Activities

 

 

77,434,086

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net Change in Cash

 

 

549,479

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Cash, Beginning of period

 

 

-

 

 

 

-

 

Cash, End of period

 

$549,479

 

 

$-

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosure of Non-Cash Information:

 

 

 

 

 

 

 

 

Issuance of representative shares

 

$515,789

 

 

$-

 

Initial measurement of carrying value to redemption value

 

$11,359,345

 

 

$-

 

Remeasurement of carrying value to redemption value

 

$271,205

 

 

$-

 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 
6

Table of Contents

 

Southern Cross Acquisition II Corp.

 

Notes To Unaudited Financial Statements

 

Note 1 — Organization, Business Operation and Going Concern Consideration

 

Southern Cross Acquisition II Corp. (the “Company”), was incorporated on September 30, 2025. The Company is a blank check company incorporated in the Cayman Islands as an exempted company with limited liability, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities (the “Business Combination”). To date, the Company has not selected any potential Business Combination target nor initiated any substantive discussions, directly or indirectly, with any such prospects. The Company has selected December 31 as its fiscal year end.

 

As of September 30, 2026, the Company had not commenced any operations. For the period from September 30, 2025, (inception) through September 30, 2026, the Company’s efforts have been limited to organizational activities as well as activities related to the IPO (as defined below). The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the IPO.

 

The Company’s founders include the Company’s officers, directors and Sponsor (the “Founders”). The Company’s Sponsor is Southern Cross Acquisition II Sponsor Corp., a Cayman Islands exempted company (the “Sponsor”).

 

On August 27, 2026, the Company consummated the Initial Public Offering (the “IPO”) of 7,652,630 units (the “Units”), which included 152,630 Units issued pursuant to the underwriters’ exercise in part of their over-allotment option. The Units were sold at a price of $10.00 per Unit, generating gross proceeds of $76,526,300. Each Unit consists of one ordinary share (a “Public Share”), including one right to receive one-fourth (1/4) of one ordinary share (a “Public Right”), and one redeemable warrant (a “Public Warrant”). Each four Public Rights entitle the holder thereof to receive one ordinary share upon the consummation of the Business Combination. Each whole Public Warrant entitles the holder thereof to purchase one ordinary share at an exercise price of $11.50 per share.

 

Simultaneously with the closing of the IPO, the Company consummated the sale of 224,932 units (the “Private Units”) at a price of $10.00 per Private Unit, 205,800 units to the Sponsor and 19,132 units to the underwriter, in a private placement (the “Private Placement”), generating gross proceeds of $2,249,320. The Private Units are identical to the Units sold in the IPO.

 

 
7

Table of Contents

 

The underwriters of the IPO have been granted a 45-day option to purchase up to an additional 972,370 units offered by the Company to cover over-allotments, if any. Up to 324,123 shares of the 2,875,000 ordinary shares, par value $0.0001 per share (the “Founder Shares”) (see Note 5) held by the Sponsor were forfeited on November 2, 2026 to the extent that the underwriters’ over-allotment option was expired.

 

Transaction costs amounted to $1,878,640, consisting of $805,000 underwriting commissions which was paid in cash at the closing date of the IPO, $515,789 of the Representative Shares (discussed below), and $557,851 of other offering costs. At the IPO closing date, cash of $660,417 was held outside of the trust account and is available for the payment of accrued offering costs and for working capital purposes.

 

In conjunction with the IPO, the Company issued to the underwriter 153,053 ordinary shares for no consideration (the “Representative Shares”). The fair value of the Representative Shares accounted for as compensation under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 718, “Compensation – Stock Compensation” (“ASC 718”) is included in the offering costs. The estimated fair value of the Representative Shares as of the IPO date totaled $515,789.

 

The Company’s initial Business Combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the balance in the trust account (excluding any taxes payable on the income earned on the trust account) at the time of the execution of a definitive agreement for such Business Combination. However, the Company will only complete such Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.

 

The ordinary shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. If the Company cannot complete a Business Combination within such 12-month period, unless the Company extends such period pursuant to its amended and restated memorandum and articles of association, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the trust account and not previously released to the Company (which interest shall be net of income taxes payable, and less up to $100,000 of interest to pay liquidation expenses) divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to public rights or private rights. The rights will expire worthless if the Company fails to complete a Business Combination within the 12-month time period.

 

Liquidity and Capital Resources

 

As of September 30, 2026, the Company had cash of $549,479 and working capital of $411,271. Following the consummation of the IPO, the Company’s liquidity needs are expected to be satisfied through the funds held outside the Trust Account and, if necessary, Working Capital Loans (defined below) from the Company’s founders, officers and directors or their affiliates or designees.

 

 
8

Table of Contents

 

In order to fund working capital deficiencies or finance transaction costs in connection with an initial Business Combination or to extend the Company’s life, the Company’s founders, officers and directors or their affiliates or designees may, but are not obligated to, loan the Company funds as may be required. The Working Capital Loans would be evidenced by promissory notes and would either be repaid upon consummation of the Company’s initial Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of such Working Capital Loans may be converted upon consummation of the initial Business Combination into Working Capital Units (defined below) at a price of $10.00 per unit. If the Company does not complete an initial Business Combination, the Working Capital Loans will not be repaid. As of September 30, 2026, the Company had no borrowings outstanding under any Working Capital Loans.

 

In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements—Going Concern,” management believes that the funds held outside the Trust Account, together with the availability of Working Capital Loans, if necessary, will be sufficient to meet the Company’s working capital needs for at least one year from the date the financial statements are issued. However, the Company is required to complete an initial Business Combination within 12 months from the closing of the IPO, unless such period is extended pursuant to the Company’s amended and restated memorandum and articles of association. If the Company is unable to complete an initial Business Combination within the required period, the Company will cease all operations except for the purpose of winding up, redeem the Public Shares and thereafter liquidate and dissolve, subject to its obligations under applicable law. The mandatory liquidation date is less than one year after the date these financial statements are issued. Accordingly, management has determined that the mandatory liquidation provision raises substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financial statements are issued. The financial statements do not include any adjustments that might result from the Company’s inability to continue as a going concern.

 

Note 2 — Significant accounting policies

 

Basis of Presentation

 

The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The interim financial information provided is unaudited but includes all adjustments which management considers necessary for the fair presentation of the results for the period. Operating results for the interim period ended September 30, 2026 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2026.

 

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart The Company’s Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

 

 
9

Table of Contents

 

Use of Estimates

 

The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

Cash consists of cash on hand and deposits placed with banks or other financial institutions and have original maturities of less than three months. The Company had $549,479 and $0 cash in bank as of September 30, 2026 and December 31, 2025, respectively.

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2026 and December 31, 2025.

 

Investments Held in Trust Account

 

As of September 30, 2026 and December 31, 2025, substantially all of the assets of $76,988,821 and $0, respectively, held in the trust account, which are invested primarily in money market funds. These investments are presented on the balance sheet at fair value at the end of each reporting period. Earnings on these investments are included in interest and dividends income in the accompanying statements of operations and are automatically reinvested. The fair value for these investments is determined using quoted market prices in active markets. 

 

Offering Costs

 

The Company complies with the requirements of ASC 340-10-S99 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A, “Expenses of Offering.” Offering costs consist principally of professional and registration fees that are directly related to the IPO. The Company allocated the proceeds from the IPO among the ordinary shares, Public Rights and Public Warrants included in the Units using the residual method, whereby the proceeds were first allocated to the Public Rights and Public Warrants based on their respective fair values, with the residual proceeds allocated to the ordinary shares. Offering costs were allocated to the underlying instruments based on the same allocation methodology. Offering costs allocated to the Public Shares were charged to temporary equity, while offering costs allocated to the Public Rights, Public Warrants and Private Placement Units were charged to shareholders’ equity (deficit), as the Public Rights, Public Warrants and the securities underlying the Private Placement Units were classified as equity.

 

Share-Based Compensation

 

The Company accounts for share-based compensation in accordance with ASC Topic 718, Compensation—Stock Compensation (“ASC 718”). Share-based awards issued or transferred to employees, directors and nonemployees in exchange for services provided to the Company are measured based on the fair value of the awards on the grant date.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

 

 

 
10

Table of Contents

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company has identified Cayman Islands as its only “major” tax jurisdiction, as defined. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements.

 

The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws.

 

The Company’s tax provision was deemed to be de minimis for the period presented. The Company is considered to be an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States.

 

Warrant and Rights Instruments

 

The Company accounts for the Public Warrants, Private Warrants, Public Rights and Private Rights issued in connection with the IPO and the sale of Private Placement Units in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging.” Based on its evaluation of the terms of the warrants and rights, the Company determined that such instruments qualify for equity classification. Accordingly, the warrants and rights are recorded in shareholders’ equity and are not subsequently remeasured.

 

Over-Allotment Liability

 

The underwriters’ over-allotment option is deemed to be a freestanding financial instrument indexed on the shares subject to redemption and are accounted for as a liability pursuant to FASB ASC Topic 480 since the underwriters’ over-allotment option was not exercised in full at the time of the IPO. The over-allotment liability is initially measured at fair value at IPO and subsequently remeasured at fair value through earnings until exercise or expiration.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist of one cash account in a financial institution located in the United States. The Company has not experienced losses on these accounts, and management believes the Company is not exposed to significant risks. The Federal Deposit Insurance Corporation (FDIC) provides standard insurance coverage of $250,000 per insured bank for each account ownership category. As of September 30, 2026, the Company had not experienced losses on these accounts. As of September 30, 2026 and December 31, 2025, the Company had deposited $549,479 and $0, respectively, with a financial institution in the United States. Of these balances $299,479 and $0, respectively, were not covered by deposit insurance. While management believes that the financial institution is of high credit quality, it also continually monitors its credit-worthiness.

 

 

 
11

Table of Contents

 

Ordinary Shares Subject to Possible Redemption

 

The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with FASB ASC 480-10-S99, the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and retained earnings (accumulated deficit). Accordingly, as of September 30, 2026, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheet. As of September 30, 2026, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:

 

Gross proceeds

 

$76,526,300

 

Less:

 

 

 

 

Proceeds allocated to Public Rights and Warrants

 

 

(9,308,924 )

Proceeds allocated to over-allotment option

 

 

(223,645 )

Public Shares issuance costs

 

 

(1,635,460 )

Plus:

 

 

 

 

Initial measurement of carrying value to redemption value

 

 

11,359,345

 

Remeasurement of carrying value to redemption value

 

 

271,205

 

Ordinary shares subject to possible redemption, September 30, 2026

 

$76,988,821

 

 

Net Income (Loss) Per Share

 

The Company complies with accounting and disclosure requirements of FASB ASC 260, “Earnings Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Remeasurement of carrying value to redemption value of redeemable ordinary shares is excluded from income (loss) per share as the redemption value approximates fair value. For the three and nine months ended September 30, 2026, the Company has not considered the effect of the Rights and Warrants included in the IPO and Private Placement Units in the calculation of diluted net income (loss) per share, since the conversion of the Rights and exercise of Warrants are contingent upon the occurrence of future events and the inclusion of such Rights and Warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.

 

 

 

For The Three Months Ended

September 30, 2026

 

 

 

 

 

Non-

 

 

 

Redeemable

 

 

Redeemable

 

 

 

Ordinary

Shares

 

 

Ordinary

Shares

 

Basic and diluted net income per ordinary share:

 

 

 

 

 

 

Numerators:

 

 

 

 

 

 

Allocation of net income

 

$30,630

 

 

$28,792

 

Denominators:

 

 

 

 

 

 

 

 

Basic and diluted weighted average shares outstanding(1)

 

 

2,828,146

 

 

 

2,658,492

 

Basic and diluted net income per ordinary share

 

$0.01

 

 

$0.01

 

 

 
12

Table of Contents

 

 

 

 

 

For The Period From

 

 

 

 

 

September 30, 2025

 

 

 

For The Nine Months Ended

 

 

(Inception) Through

 

 

 

September 30, 2026

 

 

September 30, 2025

 

 

 

Redeemable

 

 

Non-Redeemable

 

 

Redeemable

 

 

Non-Redeemable

 

 

 

Ordinary

 

 

Ordinary

 

 

Ordinary

 

 

Ordinary

 

 

 

Shares

 

 

Shares

 

 

Shares

 

 

Shares

 

Basic and diluted net income (loss) per ordinary share:

 

 

 

 

 

 

 

 

 

 

 

 

Numerators:

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of net income (loss)

 

$3,298

 

 

$8,805

 

 

$-

 

 

$(3,683 )

Denominators:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted weighted average shares outstanding(1)(2)

 

 

953,075

 

 

 

2,544,092

 

 

 

-

 

 

 

2,500,000

 

Basic and diluted net income (loss) per ordinary share

 

$0.00

 

 

$0.00

 

 

$-

 

 

$(0.00)

 

(1) 

This number includes an aggregate of up to 324,123 ordinary shares, which were forfeited on November 2, 2026, as the over-allotment option expired on October 11, 2026 (see Note 5).

 

 

(2)

On May 26, 2026, (i) the Sponsor acquired 2,875,000 founder shares for a purchase price of $25,000, and (ii) the Sponsor surrendered 1 ordinary share, all share amounts have been retroactively restated to reflect this issuance, and surrender of shares (see Note 5).

 

Recent Accounting Pronouncements

 

In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements — codification amendments in response to SEC’s disclosure Update and Simplification initiative which amend the disclosure or presentation requirements of codification subtopic 230-10 Statement of Cash Flows—Overall, 250-10 Accounting Changes and Error Corrections— Overall, 260-10 Earnings Per Share— Overall, 270-10 Interim Reporting— Overall, 440-10 Commitments—Overall, 470-10 Debt—Overall, 505-10 Equity—Overall, 815-10 Derivatives and Hedging—Overall, 860-30 Transfers and Servicing—Secured Borrowing and Collateral, 932-235 Extractive Activities— Oil and Gas—Notes to Financial Statements, 946-20 Financial Services— Investment Companies— Investment Company Activities, and 974-10 Real Estate—Real Estate Investment Trusts—Overall. The amendments represent changes to clarify or improve disclosure and presentation requirements of above subtopics. Many of the amendments allow users to more easily compare entities subject to the SEC’s existing disclosures with those entities that were not previously subject to the SEC’s requirements. Also, the amendments align the requirements in the Codification with the SEC’s regulations. For entities subject to existing SEC disclosure requirements or those that must provide financial statements to the SEC for securities purposes without contractual transfer restrictions, the effective date aligns with the date when the SEC removes the related disclosure from Regulation S-X or Regulation S-K. Early adoption is not allowed. For all other entities, the amendments will be effective two years later from the date of the SEC’s removal. If the SEC has not removed the applicable requirements by June 30, 2027, the related amendments will not become effective. The Company is currently evaluating the impact of the update on the Company’s unaudited financial statements and related disclosures.

 

On November 4, 2024, the FASB issued ASU No. 2024-03, Expense Disaggregation Disclosures (“ASU 2024-03”). ASU 2024-03 amends ASC 220, Comprehensive Income to expand income statement expense disclosures and require disclosure in the notes to the financial statements of specified information about certain costs and expenses. In January 2025, the FASB issued ASU No. 2025-01, which clarified the effective date of ASU 2024-03. ASU 2024-03 is required to be adopted for fiscal years commencing after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting the standard on its unaudited financial statements.

 

 
13

Table of Contents

 

In November 2024, the FASB issued ASU 2024-04, Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which clarifies the accounting guidance for induced conversions of convertible debt. The amendments clarify that, to account for a settlement as an induced conversion, an inducement offer must provide at least the consideration (in form and amount) issuable under the original conversion terms, even for instruments with cash conversion features. The amendments also clarify that the guidance applies to instruments not currently convertible, provided they had a substantive conversion feature at issuance and at the time of the inducement offer. The amendments aim to improve the relevance and consistency in application of the induced conversion guidance and are effective for annual periods beginning after December 15, 2025, with early adoption permitted for entities that have adopted ASU 2020-06. The Company is currently evaluating the impact of the update on the Company’s unaudited financial statements and related disclosures.

 

Except as mentioned above, the Company does not believe that any recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Company’s unaudited financial statements.

 

Note 3 —Initial Public Offering

 

On August 27, 2026, the Company consummated the IPO of 7,652,630 units (the “Units”), which included 152,630 Units issued pursuant to the underwriters’ exercise in part of their over-allotment option. The Units were sold at a price of $10.00 per Unit, generating gross proceeds of $76,526,300. Each Unit consists of one ordinary share (a “Public Share”), one right to receive one-fourth (1/4) of one ordinary share (a “Public Right”), and one redeemable warrant (a “Public Warrant”). Each four Public Rights entitle the holder thereof to receive one ordinary share upon the consummation of the Business Combination. Each whole Public Warrant entitles the holder thereof to purchase one ordinary share at an exercise price of $11.50 per share. Each Public Warrant will become exercisable on the later of (i) 30 days after the completion of an initial Business Combination and (ii) one year from the effective date of the registration statement related to the IPO, and will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Company has also granted the underwriters a 45-day option to purchase up to an additional 972,370 Units to cover over-allotments, if any. The option expired on October 11, 2026.

 

Note 4 — Private Placement

 

Simultaneously with the closing of the IPO, the Sponsor and the underwriter purchased 205,800 units and 19,132 units, respectively (collectively, the “Private Units”), at a price of $10.00 per Private Unit, for an aggregate purchase price of $2,058,000 and $191,320, respectively, in a private placement (the “Private Placement”). The Private Units are identical to the Units sold in the IPO. Each Private Unit consists of one ordinary share (a “Private Share”), one right to receive one-fourth (1/4) of one ordinary share (a “Private Right”), and one redeemable warrant (a “Private Warrant”). Each four Private Rights entitle the holder thereof to receive one ordinary share upon the consummation of the Business Combination, and each whole Private Warrant entitles the holder thereof to purchase one ordinary share at an exercise price of $11.50 per share. No fractional warrants will be issued upon separation of the Private Units and only whole warrants will trade. The underwriters’ option to purchase up to purchase an additional 972,370 Units to cover over-allotments expired on October 11, 2026, accordingly, the 2,431 additional private shares were not issued to underwriters.

 

The Sponsor and the underwriter have agreed to waive their redemption rights with respect to their Private Units (i) in connection with the consummation of a business combination, (ii) in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business Combination or to redeem 100% of the Company’s public shares if the Company does not complete its initial Business Combination within 12 months after the closing of this offering, and (iii) if the Company fails to consummate a Business Combination within 12 months after the closing of the IPO or if the Company liquidates prior to the expiration of the 12-month period. However, the Sponsor and the underwriter will be entitled to redemption rights with respect to any public shares held by it if the Company fails to consummate a Business Combination or liquidates within the 12-month period.

 

The Sponsor and the underwriter have agreed not to transfer, sell or assign the Private Units and the underlying securities until the consummation of the Company’s initial Business Combination.

 

 
14

Table of Contents

 

Note 5 — Related Party Transactions

 

Founder Shares

 

On September 30, 2025, the Company issued 1 ordinary share of a par value of $0.0001 to Mapcal Limited, which was transferred to the Sponsor on the same day without consideration. On May 26, 2026, the Company issued 2,875,000, ordinary shares as founder shares (the “Founder Shares”) to the Sponsor, for an aggregate purchase price of $25,000.

 

On August 27, 2026, the Sponsor transferred an aggregate of 55,000 Founder Shares to the Company’s officers and independent director nominees for aggregate consideration of $478, or approximately $0.0087 per share. The transfer consisted of 15,000 Founder Shares to Ally Tong Zhang, the director, Chairwoman and Chief Executive Officer (“CEO”) of the Company, for $130, 10,000 Founder Shares to Xin Wang, the Chief Financial Officer (“CFO”) of the Company, for $87, and 30,000 Founder Shares to three independent directors nominees, for $261. The Sponsor, above mentioned officers, and the independent director nominees are collectively referred to as the “Founders.”

 

The transfer of the 55,000 Founder Shares to the Company’s officers and independent director nominees was accounted for in accordance with FASB ASC Topic 718, “Compensation—Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured based on the grant-date fair value of the awards. The total fair value of the 55,000 Founder Shares transferred was approximately $184,322, or $3.36 per share.

 

The Founder Shares included an aggregate of up to 324,123 Founder Shares that were subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full. The 324,123 Founder Shares were subsequently forfeited on November 2, 2026.

 

The Founders Shares are designated as ordinary shares and are identical to the Private Placement Shares except for the following (a) Founder Shares must be voted in favor of any proposed Business Combination and cannot vote for amendments that would prevent public shareholders from converting or selling their shares in connection with a Business Combination, (b) Founder Shares cannot be converted into cash from the Trust Account in connection with a shareholder vote to approve the initial Business Combination or amend shareholders’ rights or pre-Business Combination activity. They do not participate in liquidating distributions if a Business Combination is not consummated. (c) Founder Shares cannot be transferred, assigned, or sold until the earlier of three months after the initial Business Combination or upon certain triggering events (e.g., liquidation, merger). If the share price exceeds $12.00 for 20 out of 30 trading days period commencing at least 90 days after a Business Combination, the lock-up is released.

 

Promissory Note — Related Party

 

On May 26, 2026, the Company issued a promissory note to the Sponsor to evidence the loan provided to the Company by the Sponsor, pursuant to which the Sponsor agreed to loan the Company up to $500,000 to pay formation costs and a portion of the expenses of the IPO. Prior to the closing of the IPO, the Company had drawn down an aggregate of $378,683 under the promissory note

 

This loan is non-interest bearing, unsecured and is due at the earlier of (1) June 30, 2027 or (2) the date on which the Company consummates the IPO, unless accelerated upon the occurrence of an Event of Default. In connection with the closing of the IPO on August 27, 2026, $328,000 of the outstanding balance under the promissory note was settled, and the remaining $50,683 was repaid to the Sponsor on August 28, 2026. As of September 30, 2026, no amount remained outstanding under the promissory note.

 

Working Capital Loans

 

In addition, in order to meet with the Company’s working capital needs following the consummation of this offering or to extend the Company’s life, the Company’s founders, officers and directors or their affiliates/designees may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. The loans (the “Working Capital Loans”) would be evidenced by promissory notes. The notes would either be paid upon consummation of our initial Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of the notes may be converted upon consummation of our Business Combination into working capital units (the “Working Capital Units”) at a price of $10.00 per unit in addition to the convertible notes in connection with the potential extensions. The Company’s shareholders have approved the issuance of the Working Capital Units and underlying securities upon conversion of such notes, to the extent the holder wishes to convert them at the time of the consummation of our initial Business Combination. If the Company does not complete a Business Combination, the loans will not be repaid.

 

 

 
15

Table of Contents

 

Extension Loans

 

The Founders, officers and directors, or their affiliates or designees may loan (the “Extension Loans”) the Company funds in support of its potential extension to allow additional time for the Company to complete an initial business combination, which will be evidenced in extension convertible notes, or the “extension notes,” to be repaid in cash or, at the lender’s discretion, converted into units at a price of $10.00 per unit (the “Extension Units”) at the closing of our initial business combination. The Company’s shareholders have approved the issuance of the Extension Units and underlying securities upon conversion of such extension notes, to the extent the holder wishes to convert them at the time of the consummation of our initial Business Combination. If the Company does not complete a Business Combination, the loans will not be repaid.

 

The Working Capital Units and Extension Units would be identical to the Private Units sold in the Private Placement. The terms of such loans by the Sponsor or its affiliates, if any, have not been determined and no written agreements exist with respect to such loans.

 

As of September 30, 2026, the Company had no borrowings under the Working Capital Loans and Extension Loans, respectively.

 

Note 6 — Commitments and Contingencies

 

Registration Rights

 

The holders of the Founder Shares and Private Units, Working Capital Units and Extension Units and any underlying securities will be entitled to registration rights pursuant to a registration rights agreement signed on the effective date of  IPO requiring the Company to register such securities for resale. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the Company’s initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Company granted the underwriter a 45-day option from the date of IPO to purchase up to an additional 972,370 units to cover over-allotments, if any. The option expired on October 11, 2026.

 

The Company paid a fixed underwriting discount of $805,000 (whether or not the over-allotment option is exercised) to the underwriters at the closing of the IPO in addition to the issuance of the Representative Shares.

 

Note 7 — Shareholders’ Equity

 

Preferred Shares

 

The Company is authorized to issue 10,000,000 preferred shares, with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2026 and December 31, 2025, there were no preferred shares issued or outstanding.

 

 

 
16

Table of Contents

 

Ordinary Shares

 

The Company is authorized to issue 490,000,000 ordinary shares, with a par value of $0.0001 per share. As of September 30, 2026 and December 31, 2025, 3,252,985 and 2,875,000 ordinary shares issued or outstanding (excluding 7,652,630 and 0 shares subject to possible redemption), respectively.

 

On September 30, 2025, the Company issued 1 ordinary share of a par value of $0.0001 to Mapcal Limited, which was transferred to the Sponsor on the same day without consideration

 

On May 26, 2026, the Company issued 2,875,000, ordinary shares as founder shares to the Sponsor, for an aggregate purchase price of $25,000.

 

On August 27, 2026, the Sponsor transferred 15,000 Founder Shares to the CEO, 10,000 Founder Shares to the CFO, and 30,000 Founder Shares to independent director nominees, for an aggregate of 55,000 Founder Shares.

 

The Founder Shares included an aggregate of up to 324,123 Founder Shares that were subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full. The 324,123 Founder Shares were subsequently forfeited on November 2, 2026.

 

The Company issued to the underwriter 153,053 ordinary shares (the “Representative Shares”) in connection with the consummation of the IPO, including the underwriters’ exercise in part of the over-allotment option. The underwriter has agreed not to transfer, assign or sell any such shares until the completion of the Company’s initial Business Combination. In addition, the underwriter has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of the Company’s initial Business Combination or a shareholder vote to approve an amendment to the Company’s governing documents to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination; (ii) to waive its rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete its initial Business Combination within the prescribed time period; and (iii) to vote for any proposal in connection with a Business Combination or proposal to amend the then-existing memorandum and articles of association, as amended, to modify the amount of time or substance the Company has to consummate an initial Business Combination.

 

The Representative Shares are subject to a lock-up for a period of 180 days immediately following the commencement of sales of the IPO pursuant to FINRA Rule 5110(e)(1). Pursuant to this FINRA lock-up, these securities cannot be sold, transferred, assigned, pledged or hypothecated or be subject to any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days from the commencement of sales of the IPO, except as permitted under FINRA Rule 5110(e)(2), including transfers to any underwriter and selected dealer participating in the offering and their officers or partners, registered persons or affiliates.

 

Shareholders of ordinary shares are entitled to one vote for each share held on all matters to be voted on by shareholders. Unless specified in the Company’s amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies Act or applicable share exchange rules, the affirmative vote of a majority of the Company’s issued and outstanding ordinary shares that are voted at a shareholder meeting (in person or by proxy) is required to approve any such matter voted on by the Company’s shareholders. Approval of certain actions will require a special resolution under Cayman Islands law and pursuant to the Company’s amended and restated memorandum and articles of association; such actions include amending the Company’s amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another company.

 

The Company’s board of directors will be divided into three classes, each of which will generally serve for a term of three years with only one class of directors being elected in each year. There is no cumulative voting with respect to the election of directors, with the result that the holders of more than 50% of the shares voted for the election of directors can elect all of the directors. The Company’s shareholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefore.

 

 

 
17

Table of Contents

 

Rights

 

Each holder of a right will automatically receive one-fourth (1/4) of one ordinary share upon consummation of the Company initial Business Combination, even if the holder of such right redeemed all ordinary shares held by it in connection with the initial Business Combination or an amendment to the Company’s amended and restated memorandum and articles of association with respect to our pre-business combination activities. In the event the Company will not be the surviving company upon completion of its initial Business Combination, each right will automatically be converted to receive the kind and amount of securities or properties of the surviving entity that each one-fourth of a share of ordinary shares underlying each right is entitled to upon consummation of the Business Combination, subject to any dissenter rights under the applicable law. No additional consideration will be required to be paid by a holder of rights in order to receive its additional ordinary shares upon consummation of an initial Business Combination. The shares issuable upon the conversion of the rights will be freely tradable (except to the extent held by the Company’s affiliates). If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the ordinary shares will receive in the transaction on an as-converted into ordinary shares basis.

 

The Company will not issue fractional shares in connection with a conversion of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of the Companies Act and any other applicable law. As a result, the holders hold rights in multiples of four in order to receive shares for all of your rights upon closing of a business combination. If the Company is unable to complete an initial business combination within the required time period and liquidate the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Additionally, in no event will be required to net cash settle the rights. Accordingly, the rights may expire worthless.

 

The Company shall reserve such amount of its profits or share premium in order to pay up the par value of each share issuable in respect of the rights.

 

As of September 30, 2026, there were 7,652,630 Public Rights and 224,932 Private Rights outstanding.

 

Warrants

 

Each whole warrant entitles the holder to purchase one ordinary share at an exercise price of $11.50 per share, subject to adjustment pursuant to the terms of the warrant agreement. The warrants become exercisable on the later of (i) 30 days after the completion of the Company’s initial business combination and (ii) one year from the effective date of the registration statement related to the Company’s IPO, and expire five years after the completion of the initial business combination, unless earlier redeemed or liquidated.

 

The Company is not obligated to deliver ordinary shares pursuant to the exercise of a warrant unless a registration statement under the Securities Act covering the issuance of the ordinary shares underlying the warrants is then effective and a current prospectus relating thereto is available, subject to the Company’s obligations to use its best efforts to maintain the effectiveness of such registration statement. If a registration statement covering the ordinary shares issuable upon exercise of the warrants is not effective within 60 business days following the consummation of the initial business combination, holders may exercise the warrants on a cashless basis pursuant to an available exemption under the Securities Act.

 

The exercise price and redemption trigger price are subject to adjustment in certain circumstances, including if the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at a price below $9.20 per share and specified conditions are met.

 

The Company may redeem the outstanding warrants, in whole and not in part, at a price of $0.01 per warrant upon not less than 30 days’ prior written notice, if the closing price of the Company’s ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading-day period ending three business days before the Company sends the notice of redemption, provided that an effective registration statement covering the ordinary shares issuable upon exercise of the warrants is available throughout the redemption period.

 

 

 
18

Table of Contents

 

If the Company elects to redeem the warrants, the Company may require holders to exercise their warrants on a cashless basis. In addition, if the ordinary shares are not listed on a national securities exchange and do not qualify as “covered securities” under applicable securities laws, the Company may require holders to exercise the warrants on a cashless basis in accordance with Section 3(a)(9) of the Securities Act.

 

As of September 30, 2026, there were 7,652,630 Public Warrants and 224,932 Private Warrants outstanding.

 

Note 8 — Fair Value Measurements

 

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

 

●

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

 

 

●

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

 

 

●

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

Representative Shares

 

The fair value of the Representative Shares was approximately $515,789, or $3.37 per Representative Share, at the issuance date. In connection with the IPO, the Company agreed to issue 153,053 ordinary shares to the representative of the underwriters and/or its designees. The fair value of the Representative Shares was determined using a Black-Scholes model, adjusted for a discount for lack of marketability and the estimated probability of successfully completing an initial Business Combination. The following table presents the quantitative information regarding the significant assumptions used in the Level 3 valuation of the Representative Shares:

 

 

 

August 27,

2026

 

Underlying stock price

 

$8.78

 

Exercise price

 

$0.00

 

Volatility

 

 

15.0%

Remaining term (in years)

 

 

1.00

 

Risk-free rate

 

 

4.0%

Dividend yield

 

 

0.0%

Discount of lack of marketability

 

 

4.1%

Probability of completion of Business Combination

 

 

40.0%

 

 
19

Table of Contents

 

Founder Shares

 

The Company established the fair value of the 55,000 Founder Shares transferred to the Company’s officers and independent director nominees using a valuation prepared by a third-party valuation firm using a Black-Scholes model. The valuation incorporated an estimated probability of successfully completing an initial Business Combination. The fair value of the Founder Shares was approximately $184,800 in the aggregate, or $3.36 per Founder Share, as of August 27, 2026. The following table presents the quantitative information regarding the significant assumptions used in the Level 3 valuation of the Founder Shares:

 

 

 

August 27,

2026

 

Underlying stock price

 

$8.78

 

Exercise price

 

$0.00

 

Volatility

 

 

15.0%

Remaining term (in years)

 

 

1.25

 

Risk-free rate

 

 

4.1%

Dividend yield

 

 

0.0%

Discount of lack of marketability

 

 

4.4%

Probability of completion of Business Combination

 

 

40.0%

 

Public Warrants

 

The fair value of the Public Warrants was approximately $2,601,894, or $0.34 per Public Warrant, at the issuance date. The fair value of the Public Warrants was determined using a Black-Scholes model. The Public Warrants have been classified within shareholders’ equity and will not require subsequent remeasurement after issuance. The following table presents the quantitative information regarding the significant assumptions used in the Level 3 valuation of the Public Warrants:

 

 

 

August 27,

2026

 

Underlying stock price

 

$8.78

 

Exercise price

 

$11.50

 

Volatility

 

 

10.0%

Remaining term (in years)

 

 

6.01

 

Risk-free rate

 

 

4.5%

Dividend yield

 

 

0.0%

Probability of completion of Business Combination

 

 

40.0%

 

Public Rights

 

The fair value of the Public Rights was approximately $6,734,314, or $0.88 per Public Right, at the issuance date. The fair value of the Public Rights was determined using a Black-Scholes model based on the contractual terms of the Public Rights, pursuant to which each Public Right entitles the holder to receive one-fourth (1/4) of one ordinary share upon consummation of the Company’s initial Business Combination. The Public Rights have been classified within shareholders’ equity and will not require subsequent remeasurement after issuance. The following table presents the quantitative information regarding the significant assumptions used in the Level 3 valuation of the Public Rights:

 

 

 

August 27,

2026

 

Underlying stock price

 

$2.20

 

Exercise price

 

$0.00

 

Volatility

 

 

15.0%

Remaining term (in years)

 

 

1.00

 

Risk-free rate

 

 

4.0%

Dividend yield

 

 

0.0%

Probability of completion of Business Combination

 

 

40.0%

 

 
20

Table of Contents

 

Over-Allotment Liability

 

The fair value of the over-allotment liability was approximately $223,645 and $128,499, or $0.23 and $0.13 per Unit, on August 27, 2026 and September 30, 2026, respectively. The fair value of the over-allotment liability was determined using a Black-Scholes model, adjusted for a discount for lack of marketability and the estimated probability of successfully completing an initial Business Combination. The following tables present the quantitative information regarding the significant assumptions used in the Level 3 valuation of the over-allotment liability:

 

 

 

August 27,

2026

 

Underlying stock price

 

$10.00

 

Exercise price

 

$10.00

 

Volatility

 

 

15.0%

Remaining term (in years)

 

 

0.12

 

Risk-free rate

 

 

3.7%

Dividend yield

 

 

0.0%

Probability of completion of Business Combination

 

 

40.0%

 

 

 

September 30,

2026

 

Underlying stock price

 

$10.04

 

Exercise price

 

$10.00

 

Volatility

 

 

15.0%

Remaining term (in years)

 

 

0.03

 

Risk-free rate

 

 

4.0%

Dividend yield

 

 

0.0%

Probability of completion of Business Combination

 

 

40.0%

 

Note 9 — Segments

 

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s CODM, or group, in deciding how to allocate resources and assess performance.

 

The Company’s CODM has been identified as the Chief Executive Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment.

 

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statement of operations as net income or loss. The net loss is the measure of segment profit (loss) most consistent with U.S. GAAP that is regularly reviewed by the CODM to allocate resources and assess financial performance. The Company does not have an operating income and therefore, it does not have any revenue. The Company will not generate any operating revenues until after the completion of the Business Combination, at the earliest. The Company’s significant expenses were formation and operating costs. The measure of segment assets is reported on the balance sheet as total assets.

 

 
21

Table of Contents

 

When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:

 

 

 

For The

Three Months

Ended

September 30,

2026

 

 

For The

Nine Months

Ended

September 30,

2026

 

 

For the Period From

 September 30, 2025

(Inception) Through

September 30,

2025

 

Formation and operating costs

 

$(122,607)

 

$(169,926)

 

$(3,683)

Stock compensation expense

 

 

(184,322)

 

 

(184,322)

 

 

-

 

Change in fair value of over-allotment liability

 

 

95,146

 

 

 

95,146

 

 

 

-

 

Interest and dividend income on investments held in Trust Account

 

 

271,205

 

 

 

271,205

 

 

 

-

 

Net income (loss)

 

$59,422

 

 

$12,103

 

 

$(3,683)

 

As of September 30, 2026 and December 31, 2025, the Company had total assets of $77,618,789 and $0, respectively. See the Company’s balance sheet for additional information.

 

Note 10 — Subsequent Events

 

The Company’s management reviewed all material events that occurred after the balance sheet date up to the date that the financial statements were issued. Based on the review, except described below, management did not identify any subsequent events that are required disclosure in the financial statements.

 

The Company granted the underwriter a 45-day option from the date of IPO to purchase up to an additional 972,370 units to cover over-allotments. The option expired on October 11, 2026, and the 324,123 Founder Shares held by the Sponsor were forfeited on November 2, 2026.

 

 
22

Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

 

This Quarterly Report on Form 10-Q includes forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings. References to the “Company”, “us,” “our,” or “we” refer to Southern Cross Acquisition II Corp. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited financial statements and related notes herein.

 

Overview

 

We are a blank check company incorporated as a Cayman Islands exempted company with limited liability on September 30, 2025, for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities, which we refer to as a “target business.” Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region. To date, we have not selected any potential target business nor initiated any substantive discussions, directly or indirectly, with any such prospect. We have selected December 31 as our fiscal year end.

 

We presently have no revenue, have incurred formation and operating costs since inception, and have had no operations other than identifying and evaluating suitable acquisition transaction candidates. Prior to the consummation of the IPO (as defined below), our liquidity needs were satisfied through advances from our Sponsor (as defined below) pursuant to an unsecured promissory note. Following the consummation of the IPO and the Private Placement (as defined below), we have relied upon the working capital held outside the Trust Account (as defined below) to fund our operations, as well as any funds loaned by the Sponsor, our officers, directors or their affiliates. We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to raise capital or to complete our initial business combination will be successful.

 

On August 27, 2026, we consummated the initial public offering (the “IPO”) of 7,652,630 units (the “Units”), which included 152,630 Units issued pursuant to the underwriters’ partial exercise of their over-allotment option. Each Unit consists of one ordinary share, $0.0001 par value per share (each, an “Ordinary Share”), one right (each, a “Right”) entitling the holder thereof to receive one-fourth (1/4) of one Ordinary Share upon the consummation of the Company’s initial business combination, and one redeemable warrant (each, a “Warrant”), each whole Warrant entitling the holder thereof to purchase one Ordinary Share at an exercise price of $11.50 per share. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $ 76,526,300. D. Boral Capital LLC acted as the representative of the underwriters of the IPO (the “Representative”).

 

Simultaneously with the consummation of the IPO, we consummated the private placement of 224,932 units (the “Private Units”) to our Sponsor, Southern Cross Acquisition II Sponsor Corp. (the “Sponsor”), and the Representative, at a price of $10.00 per Private Unit, generating gross proceeds of $2,249,320 (the “Private Placement”). The Private Units are identical to the Units sold in the IPO. 

 

A total of approximately $76,717,616 from the net proceeds of the IPO and the sale of the Private Units was placed in a trust account (the “Trust Account”) established for the benefit of our public shareholders and the underwriters of the IPO with Equiniti Trust Company, LLC acting as trustee.

 

We also issued to the Representative 153,053 Ordinary Shares as part of the underwriting compensation (the “Representative Shares”), which were issued upon the closing of the IPO. The Representative Shares are identical to the Ordinary Shares included in the Units, with certain exceptions.

 

Commencing on or about October 8, 2026, holders of the Units may select to separately trade on Nasdaq the Ordinary Shares, Warrants and Rights included in the Units under the symbols “SCAT,” “SCATW,” and “SCATR,” respectively. Units not separated will continue to trade on Nasdaq under the symbol “SCATU.”

 

 
23

Table of Contents

 

Results of Operations

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities from September 30, 2025 (inception) through September 30, 2026 were organizational activities, those necessary to prepare for the IPO, and after the IPO, identifying a target company for an initial business combination. We do not expect to generate any operating revenues until after the completion of our initial business combination. We may generate non-operating income in the form of interest and dividend income on investments held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing an initial business combination.

 

For the three months ended September 30, 2026, we had net income of $59,422, which consisted of interest and dividend income on investments held in the trust account of $271,205 and the change in fair value of the over-allotment liability of $95,146, partially offset by formation and operating costs of $122,607 and stock-based compensation expense of $184,322.

 

For the nine months ended September 30, 2026, we had net income of $12,103, which consisted of interest and dividend income on investments held in the trust account of $271,205 and the change in fair value of the over-allotment liability of $95,146, partially offset by formation and operating costs of $169,926 and stock-based compensation expense of $184,322.

 

For the period from September 30, 2025 (inception) through September 30, 2025, we had a net loss of $3,683, which consisted of formation and operating costs.

 

Liquidity and Capital Resources

 

Prior to the consummation of the IPO, our liquidity needs were satisfied through the payment of $25,000 by our sponsor for the founder shares and advances from our sponsor under an unsecured promissory note. On May 26, 2026, we issued a promissory note to our sponsor, pursuant to which our sponsor agreed to loan us up to $500,000 to fund formation costs and a portion of the expenses of the IPO. Prior to the closing of the IPO, we had drawn an aggregate of $378,683 under the promissory note. In connection with the closing of the IPO on August 27, 2026, $328,000 of the outstanding balance was settled and the remaining $50,683 was reclassified as due to a related party, which we repaid to our sponsor on August 28, 2026. As of September 30, 2026, no amount was outstanding under the promissory note.

 

In connection with the IPO, we incurred $1,878,640 in transaction costs, consisting of $805,000 of underwriting commissions paid in cash at the closing of the IPO, $515,789 of Representative Shares (as discussed below), and $557,851 of other offering costs. Following the closing of the IPO and the Private Placement, we had $660,417 of cash held outside of the trust account, available for the payment of accrued offering costs and for working capital purposes.

 

In conjunction with the IPO, we issued to the Representative 153,053 ordinary shares for no consideration (the “Representative Shares”). The fair value of the Representative Shares, accounted for as compensation under the Financial Accounting Standards Board’s Accounting Standards Codification (“ASC”) 718, “Compensation – Stock Compensation” (“ASC 718”), is included in the offering costs. The estimated fair value of the Representative Shares as of the IPO date totaled $515,789.

 

As of September 30, 2026, we had cash of $549,479 and working capital of $411,271.

 

For the nine months ended September 30, 2026, there was $166,991 of cash used in operating activities, resulting from interest and dividend income on investments held in the trust account of $271,205, the change in fair value of the over-allotment liability of $95,146 and the increase in prepaid expenses of $80,489, partially offset by the net income of $12,103, stock-based compensation expense of $184,322, and the increase in accrued expenses of $83,424.

 

For the period from September 30, 2025 (inception) through September 30, 2025, there was no cash used in operating activities, as the net loss of $3,683 was fully offset by formation and operating costs paid by our sponsor of $3,683.

 

For the nine months ended September 30, 2026, there was $76,717,616 of cash used in investing activities resulting from the purchase of investments held in the trust account.

 

 
24

Table of Contents

 

For the period from September 30, 2025 (inception) through September 30, 2025, there were no investing activities.

 

For the nine months ended September 30, 2026, there was $77,434,086 of cash provided by financing activities resulting from the proceeds from the IPO of $76,526,300, the proceeds from the Private Placement of $2,058,000, the proceeds from a promissory note to a related party of $375,000 and the proceeds from the issuance of founder shares of $25,000, partially offset by the payment of the underwriting discount, net of the Private Units subscription by the Representative, of $723,680, the payment of offering costs of $447,851, the repayment of a promissory note to a related party of $328,000 and the repayment of amounts due to a related party of $50,683.

 

For the period from September 30, 2025 (inception) through September 30, 2025, there were no financing activities.

 

We intend to use the funds held outside the trust account to primarily identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete an initial business combination.

 

In order to fund working capital deficiencies or finance transaction costs in connection with an initial business combination, or to extend our life, our founders, officers and directors or their affiliates or designees may, but are not obligated to, loan us funds as may be required (the “Working Capital Loans”). If we complete our initial business combination, we would repay such loaned amounts. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts, but no proceeds from the trust account would be used for such repayment. Up to $3,000,000 of the Working Capital Loans may be convertible into units at a price of $10.00 per unit (the “Working Capital Units”) at the option of the lender. In addition, our founders, officers and directors or their affiliates or designees may loan us funds in support of a potential extension of the time to complete our initial business combination (the “Extension Loans”), which would be evidenced by convertible notes that may be repaid in cash or, at the lender’s discretion, converted into units at a price of $10.00 per unit at the closing of our initial business combination. The Working Capital Units and the units issuable upon conversion of the Extension Loans would be identical to the Private Units. As of September 30, 2026, we had no borrowings under the Working Capital Loans or Extension Loans.

 

We believe we will need to raise additional funds in order to meet the expenditures required for operating our business. If our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to complete our initial business combination or because we become obligated to redeem a significant number of our Public Shares upon completion of our initial business combination, in which case we may issue additional securities or incur debt in connection with such initial business combination.

 

Off-Balance Sheet Financing Arrangements

 

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

 

Contractual Obligations

 

Registration Rights

 

The holders of the founder shares, Private Units, Working Capital Units and units issued upon conversion of the Extension Loans, and any underlying securities, are entitled to registration rights pursuant to a registration rights agreement signed on August 25, 2026, requiring us to register such securities for resale. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed after the completion of our initial business combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. We will bear the costs and expenses of filing any such registration statements.

 

 
25

Table of Contents

 

Underwriting Agreement

 

We granted the underwriters a 45-day option from the date of the prospectus for the IPO to purchase up to 1,125,000 additional Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions. On August 27, 2026, the underwriters exercised the over-allotment option in part and purchased 152,630 Units. The remaining option to purchase up to 972,370 Units expired unexercised on October 11, 2026, and, accordingly, 324,123 founder shares were forfeited by our sponsor on November 2, 2026.

 

The underwriters received a fixed cash underwriting discount of $805,000 (whether or not the over-allotment option is exercised), paid at the closing of the IPO, in addition to the issuance of the Representative Shares, pursuant to the underwriting agreement dated August 25, 2026, by and between us and D. Boral Capital LLC, as representative of the underwriters. The underwriters are not entitled to any deferred underwriting commissions.

 

Critical Accounting Estimates

 

Use of Estimates

 

The preparation of unaudited financial statements in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, actual results may differ from these estimates. We have identified the following critical accounting policies and estimates:

 

Fair Value of Financial Instruments

 

The fair value of our assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”), approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, other than the over-allotment liability discussed below.

 

We apply ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in our principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.

 

Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.

 

Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.

 

Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.

 

 
26

Table of Contents

 

The fair value of the Public Warrants was approximately $2,601,894, or $0.34 per Public Warrant, at the issuance date. The fair value of the Public Warrants was determined using a Black-Scholes model. The Public Warrants have been classified within shareholders’ equity and will not require subsequent remeasurement after issuance. The following table presents the quantitative information regarding the significant assumptions used in the Level 3 valuation of the Public Warrants:

 

 

 

August 27,

2026

 

Underlying stock price

 

$8.78

 

Exercise price

 

$11.50

 

Volatility

 

 

10.0%

Remaining term (in years)

 

 

6.01

 

Risk-free rate

 

 

4.5%

Dividend yield

 

 

0.0%

Probability of completion of business combination

 

 

40.0%

 

The fair value of the Public Rights was approximately $6,734,314, or $0.88 per Public Right, at the issuance date. The fair value of the Public Rights was determined using a Black-Scholes model based on the contractual terms of the Public Rights, pursuant to which each Public Right entitles the holder to receive one-fourth (1/4) of one ordinary share upon consummation of our initial business combination. The Public Rights have been classified within shareholders’ equity and will not require subsequent remeasurement after issuance. The following table presents the quantitative information regarding the significant assumptions used in the Level 3 valuation of the Public Rights:

 

 

 

August 27,

2026

 

Underlying stock price

 

$2.20

 

Exercise price

 

$0.00

 

Volatility

 

 

15.0%

Remaining term (in years)

 

 

1.00

 

Risk-free rate

 

 

4.0%

Dividend yield

 

 

0.0%

Probability of completion of business combination

 

 

40.0%

 

In conjunction with the IPO, we issued 153,053 Representative Shares to the Representative for no consideration. The fair value of the Representative Shares, accounted for as compensation under ASC 718 and included in offering costs, was $515,789 as of the IPO date. The fair value of the Representative Shares was determined using a Black-Scholes model, adjusted for a discount for lack of marketability and the estimated probability of successfully completing an initial business combination. The following table presents the quantitative information regarding the significant assumptions used in the Level 3 valuation of the Representative Shares:

 

 

 

August 27,

2026

 

Underlying stock price

 

$8.78

 

Exercise price

 

$0.00

 

Volatility

 

 

15.0%

Remaining term (in years)

 

 

1.00

 

Risk-free rate

 

 

4.0%

Dividend yield

 

 

0.0%

Discount of lack of marketability

 

 

4.1%

Probability of completion of business combination

 

 

40.0%

 

 
27

Table of Contents

 

Over-Allotment Liability

 

The underwriters’ over-allotment option is deemed to be a freestanding financial instrument indexed on the ordinary shares subject to possible redemption and is accounted for as a liability pursuant to ASC 480, “Distinguishing Liabilities from Equity,” since the over-allotment option was not exercised in full at the time of the IPO. The over-allotment liability was initially measured at fair value on the IPO date and is subsequently remeasured at fair value at each reporting date, with changes in fair value recognized in our statements of operations, until the option is exercised or expires. For the three and nine months ended September 30, 2026, we recognized a gain of $95,146 from the change in fair value of the over-allotment liability, which is included in our net income for each period.

 

The fair value of the over-allotment liability was approximately $223,645 and $128,499, or $0.23 and $0.13 per Unit, on August 27, 2026 and September 30, 2026, respectively. The fair value of the over-allotment liability was determined using a Black-Scholes model, adjusted for a discount for lack of marketability and the estimated probability of successfully completing an initial business combination. The following tables present the quantitative information regarding the significant assumptions used in the Level 3 valuation of the over-allotment liability:

 

 

 

August 27,

2026

 

Underlying stock price

 

$10.00

 

Exercise price

 

$10.00

 

Volatility

 

 

15.0%

Remaining term (in years)

 

 

0.12

 

Risk-free rate

 

 

3.7%

Dividend yield

 

 

0.0%

Probability of completion of business combination

 

 

40.0%

 

 

 

September 30,

2026

 

Underlying stock price

 

$10.04

 

Exercise price

 

$10.00

 

Volatility

 

 

15.0%

Remaining term (in years)

 

 

0.03

 

Risk-free rate

 

 

4.0%

Dividend yield

 

 

0.0%

Probability of completion of business combination

 

 

40.0%

 

Stock Compensation

 

We account for stock-based compensation expense in accordance with ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date and recognized over the requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. Forfeitures are recognized as incurred.

 

 
28

Table of Contents

 

On August 27, 2026, our sponsor transferred an aggregate of 55,000 founder shares to our officers and independent directors for aggregate consideration of $478, or approximately $0.0087 per share, consisting of 15,000 founder shares to Ally Tong Zhang, our Chairwoman and Chief Executive Officer, 10,000 founder shares to Xin Wang, our Chief Financial Officer, and 30,000 founder shares to our three independent directors. We established the fair value of the 55,000 founder shares transferred using a valuation prepared by a third-party valuation firm using a Black-Scholes model. The valuation incorporated an estimated probability of successfully completing an initial Business Combination. The fair value of the founder shares was approximately $184,800 in the aggregate, or $3.36 per founder share, as of August 27, 2026. We accounted for the transfer under ASC 718 as stock compensation of $184,322, which is the $184,800 fair value less the $478 paid. The following table presents the quantitative information regarding the significant assumptions used in the Level 3 valuation of the founder shares:

 

 

 

August 27,

2026

 

Underlying stock price

 

$8.78

 

Exercise price

 

$0.00

 

Volatility

 

 

15.0%

Remaining term (in years)

 

 

1.25

 

Risk-free rate

 

 

4.1%

Dividend yield

 

 

0.0%

Discount of lack of marketability

 

 

4.4%

Probability of completion of business combination

 

 

40.0%

 

Recent Accounting Pronouncements

 

In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements — codification amendments in response to SEC’s disclosure Update and Simplification initiative which amend the disclosure or presentation requirements of codification subtopic 230-10 Statement of Cash Flows—Overall, 250-10 Accounting Changes and Error Corrections— Overall, 260-10 Earnings Per Share— Overall, 270-10 Interim Reporting— Overall, 440-10 Commitments—Overall, 470-10 Debt—Overall, 505-10 Equity—Overall, 815-10 Derivatives and Hedging—Overall, 860-30 Transfers and Servicing—Secured Borrowing and Collateral, 932-235 Extractive Activities— Oil and Gas—Notes to Financial Statements, 946-20 Financial Services— Investment Companies— Investment Company Activities, and 974-10 Real Estate—Real Estate Investment Trusts—Overall. The amendments represent changes to clarify or improve disclosure and presentation requirements of above subtopics. Many of the amendments allow users to more easily compare entities subject to the SEC’s existing disclosures with those entities that were not previously subject to the SEC’s requirements. Also, the amendments align the requirements in the Codification with the SEC’s regulations. For entities subject to existing SEC disclosure requirements or those that must provide financial statements to the SEC for securities purposes without contractual transfer restrictions, the effective date aligns with the date when the SEC removes the related disclosure from Regulation S-X or Regulation S-K. Early adoption is not allowed. For all other entities, the amendments will be effective two years later from the date of the SEC’s removal. If the SEC has not removed the applicable requirements by June 30, 2027, the related amendments will not become effective. We’re currently evaluating the impact of the update on our unaudited financial statements and related disclosures. 

 

On November 4, 2024, the FASB issued ASU No. 2024-03, Expense Disaggregation Disclosures (“ASU 2024-03”). ASU 2024-03 amends ASC 220, Comprehensive Income to expand income statement expense disclosures and require disclosure in the notes to the financial statements of specified information about certain costs and expenses. In January 2025, the FASB issued ASU No. 2025-01, which clarified the effective date of ASU 2024-03. ASU 2024-03 is required to be adopted for fiscal years commencing after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. We’re currently evaluating the impact of adopting the standard on our unaudited financial statements. 

 

In November 2024, the FASB issued ASU 2024-04, Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which clarifies the accounting guidance for induced conversions of convertible debt. The amendments clarify that, to account for a settlement as an induced conversion, an inducement offer must provide at least the consideration (in form and amount) issuable under the original conversion terms, even for instruments with cash conversion features. The amendments also clarify that the guidance applies to instruments not currently convertible, provided they had a substantive conversion feature at issuance and at the time of the inducement offer. The amendments aim to improve the relevance and consistency in application of the induced conversion guidance and are effective for annual periods beginning after December 15, 2025, with early adoption permitted for entities that have adopted ASU 2020-06. We’re currently evaluating the impact of the update on our unaudited financial statements and related disclosures.

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our unaudited financial statements.

 

 
29

Table of Contents

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

 

ITEM 4. CONTROLS AND PROCEDURES 

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our current chief executive officer and chief financial officer) (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of September 30, 2026, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our chief executive officer and chief financial officer concluded that, have concluded that during the period covered by this report, our disclosure controls and procedures were not effective.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

  

Changes in Internal Control Over Financial Reporting

 

During the period covered by this quarterly report on Form 10-Q (the “Quarterly Report”), there has been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter covered by this report that has materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 
30

Table of Contents

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

We are not a party to any material legal proceedings and no material legal proceedings have been threatened by us or, to the best of our knowledge, against us. 

 

ITEM 1A. RISK FACTORS.

 

As a smaller reporting company, we are not required to include risk factors in this Report. However, factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our Prospectus. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Prospectus.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS FROM REGISTERED SECURITIES.

 

Unregistered Sales of Equity Securities

 

Substantially concurrently with the closing of the IPO, the Company completed the private sale of 224,932 Private Placement Units to the Sponsor and the Representative, for an aggregate purchase price of $2,249,320. The Private Placement Units are identical to the Units issued in the IPO, subject to limited exceptions as further described in the registration statement filed in connection with the IPO.

 

The above sales were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. No commissions were paid in connection with such sales.

 

Use of Proceeds

 

On August 27, 2026, the Company consummated its initial public offering of 7,652,630 Units, including partial exercise of the underwriters’ option to purchase an additional 152,630 units to cover over-allotments. Each Unit consists of one ordinary share, one redeemable warrant, and one right to receive one-fourth of one ordinary share. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $76,526,300.

 

Substantially concurrently with the closing of the IPO, the Company completed the private sale of 224,932 Private Placement Units to the Sponsor and the Representative for an aggregate purchase price of $2,249,320. The Private Placement Units are identical to the Units issued in the IPO, subject to limited exceptions as further described in the registration statement filed in connection with the IPO.

 

A total of approximately $76,717,616, from the proceeds received from the consummation of the IPO and simultaneous private placement (net of transaction expenses and working capital) were placed in the Company’s trust account established for the benefit of the Company’s public shareholders and the underwriters of the IPO with Equiniti Trust Company, LLC, acting as trustee.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

None.

 

 
31

Table of Contents

 

ITEM 6. EXHIBITS

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

Exhibit No.

 

Description

31.1*

 

Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2*

 

Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1**

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2**

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*

 

Inline XBRL Instance Document

101.CAL*

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.SCH*

 

Inline XBRL Taxonomy Extension Schema Document

101.DEF*

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*

 

Inline XBRL Taxonomy Extension Labels Linkbase Document

101.PRE*

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104*

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

*

Filed herewith

**

Furnished.

 

 
32

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Southern Cross Acquisition II Corp.

 

 

 

 

 

Date: November 16, 2026

By:

/s/ Ally Tong Zhang

 

 

 

Ally Tong Zhang

 

 

 

Chief Executive Officer

(Principal Executive Officer)

 

 

 

 

 

Date: November 16, 2026

By:

/s/ Xin Wang

 

 

 

Xin Wang

 

 

 

Chief Financial Officer

(Principal Financial Officer)

 

 

 
33

 

Keep reading